Veloci BioPharma Analyzer With A-TEEM Molecular Fingerprinting

The Veloci™ BioPharma Analyzer is an analytical instrument developed by HORIBA for the characterization and monitoring of complex biopharmaceutical samples, with particular relevance to cell culture media analysis. It is used in research, process development, and quality-related environments where rapid, reproducible insight into sample composition and variability is required. The system is based on A-TEEM™ technology, which combines absorbance, transmittance, and excitation–emission matrix (EEM) fluorescence measurements into a single data acquisition. 

Analytical Function
The primary function of the Veloci BioPharma Analyzer is to generate multidimensional spectral fingerprints of biological and biochemical samples. In the context of cell culture media, these fingerprints capture the combined optical signatures of amino acids, vitamins, metabolites, and other fluorescent or UV active components that contribute to media performance. A TEEM spectroscopy acquires hundreds of fluorescence spectra across a range of excitation and emission wavelengths while simultaneously collecting absorbance and transmittance data, producing a holistic representation of media composition. 

Because this approach does not rely on physical separation steps, analysis is performed without chromatography columns, solvents, or labeling reagents. Cell culture media samples can be measured in their native or minimally diluted state with little preparation, reducing handling-related variability and preserving compositional integrity. Multivariate data analysis methods can then be applied to compare media lots, monitor compositional drift over time, or assess changes introduced during storage or processing.

Application Areas
The Veloci BioPharma Analyzer is particularly well suited for applications where complex formulations make conventional single-parameter measurements insufficient. Key use cases include:
• Cell culture media analysis, enabling detection of lot-to-lot variability, degradation, or compositional shifts that may not be evident from standard release tests such as pH, osmolality, or glucose concentration
• Monitoring of media during bioprocessing, supporting trend analysis and early identification of changes that could affect cell growth or productivity
• Protein characterization, including monoclonal antibodies, to observe structural or conformational differences and early indicators of aggregation
• Vaccine formulation assessment, supporting comparative analysis and batch consistency
• Adeno-associated virus (AAV) analysis, where spectral differences can be correlated with capsid content or subtype variation
• Antibody–drug conjugates (ADCs), allowing differentiation between antibody, linker, and payload contributions using intrinsic fluorescence
Across these applications, the instrument is commonly used for comparative and trend-based analysis, rather than absolute identification of individual molecular species.

Operational Considerations
The Veloci Analyzer is designed to simplify analytical workflows. By eliminating separations, it reduces instrument setup time, consumable usage, and routine maintenance associated with columns, mobile phases, and solvent disposal. Measurements are typically completed within minutes, allowing cell culture media samples to be screened or monitored at higher frequency than is practical with many chromatographic methods.

The associated software supports storage of reference spectra, comparison of new samples to established baselines, and application of chemometric models. This functionality is particularly useful for media qualification, ongoing lot monitoring, and investigation of deviations where relative differences are more informative than absolute concentration measurements.

Value in Biopharmaceutical Development and Manufacturing
In biopharmaceutical development and manufacturing, the Veloci BioPharma Analyzer provides information-rich measurements that complement established analytical techniques. For cell culture media, it offers a practical way to assess consistency and detect changes early, without the time and resource demands of separation-based analysis. While it does not replace techniques such as LC MS for definitive compositional identification, it can be used to prioritize samples for further investigation and support process understanding.
In quality and manufacturing settings, this capability supports risk reduction by identifying unexpected media variability before it impacts cell performance or downstream product quality. In development environments, it enables rapid comparison of media formulations, suppliers, or storage conditions, supporting data-driven decisions with reduced analytical overhead.

Overall, the Veloci BioPharma Analyzer serves as a spectroscopic characterization tool that aligns with modern biopharmaceutical workflows, particularly where cell culture media consistency, trend monitoring, and process insight are important considerations.